BioSpace News Archive

Business

Cannara Biotech Inc. Reports Fiscal Second Quarter 2022 Financial Results

Cannara Biotech Inc. today announced its fiscal second quarter 2022 financial and operating results for the three and six-month periods ended February 28, 2022.

April 27, 2022
·
8 min read
Drug Development

HARMONY BIOSCIENCES INITIATES PHASE 3 TRIAL OF PITOLISANT IN ADULT PATIENTS WITH IDIOPATHIC HYPERSOMNIA

Harmony Biosciences Holdings, Inc. today announced the initiation of its Phase 3 trial evaluating the efficacy and safety of pitolisant in adult patients with idiopathic hypersomnia (IH), known as the INTUNE study.

April 27, 2022
·
11 min read
Business

Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets

Charles River Laboratories International, Inc. (NYSE: CRL) and Valo Health, Inc (“Valo”) have launched Logica TM , an artificial intelligence (AI) powered drug solution that directly translates clients’ biological insights into optimized preclinical assets.

April 27, 2022
·
4 min read
Business

Highland Therapeutics Announces Appointment of Stephanie C. Read as President/CEO, Changes to Board of Directors

Highland Therapeutics Inc. today announced the appointment of Stephanie C. Read as President/Chief Executive Officer, the appointment of Scott Myers as Chair of the Board and the additions of Kevin Bain and Ildiko Mehes as independent members of the Board of Directors.

April 27, 2022
·
12 min read
Paragon 28 Launches Paratrooper™ Plantar Plate System for Hammertoe and Soft Tissue Repair

Paragon 28, Inc. announced today an expansion of its hammertoe and soft-tissue portfolio with the launch of its Paratrooper™ Plantar Plate Repair System.

April 27, 2022
·
2 min read
Business

Arcturus Therapeutics to Report First Quarter 2022 Financial Results and Provide Corporate Update on May 9, 2022

Arcturus Therapeutics Holdings Inc. today announced that it will release its financial results for the quarter ended March 31, 2022 after the market close on Monday, May 9 and will also host a conference call and webcast at 4:30 pm Eastern Daylight Time on May 9, 2022.

April 27, 2022
·
2 min read
Antinuclear Antibody Test Market Size 2022-2028- Favorable Reimbursement And Healthcare Policies

Increasingly favorable reimbursement policies, rising prevalence of autoimmune disorders, and rapidly increasing geriatric population are some key factors fueling market growth.

April 27, 2022
·
7 min read
Capillary Blood Collection Market Analysis 2021-2028- Increasing Number Of Surgical Procedures Globally

Rising prevalence of various diseases worldwide is driving the revenue growth of the market.

April 27, 2022
·
6 min read
Diagnostic Reagent Market Growth, Revenue, Share, Analysis, Company Profiles, and Forecast To 2027

The data has been collected through extensive primary and secondary research and is validated by experts in the industry.

April 27, 2022
·
6 min read
Dried Blood Spot Collection Cards Market Size 2022-2028- Increasing Adoption Of Newborn Screening Across The Globe Is A Key Factor Driving Revenue Growth

Increasing demand for newborn screening and rising preference for less- and non-invasive blood testing methods are key factors driving market growth.

April 27, 2022
·
7 min read